Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Chemonucleolysis. Development, experiences, prospects].

R Steffen1, R von Bremen-Kühne

  • 1Orthopädische Fachklinik, Marienkrankenhaus Kaiserswerth, Düsseldorf.

Der Orthopade
|September 4, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hypomineralised second primary molars: the Würzburg concept.

European archives of paediatric dentistry : official journal of the European Academy of Paediatric Dentistry·2024
Same author

Update of the molar incisor hypomineralization: Würzburg concept.

European archives of paediatric dentistry : official journal of the European Academy of Paediatric Dentistry·2023
Same author

Tick-borne encephalitis (TBE) vaccine 'FSME-IMMUN' boosters - response to the letter by Bernard Hoet and Victoria Jenkins.

Ticks and tick-borne diseases·2021
Same author

Can the booster interval for the tick-borne encephalitis (TBE) vaccine 'FSME-IMMUN' be prolonged? - A systematic review.

Ticks and tick-borne diseases·2021
Same author

The Würzburg MIH concept: the MIH treatment need index (MIH TNI) : A new index to assess and plan treatment in patients with molar incisior hypomineralisation (MIH).

European archives of paediatric dentistry : official journal of the European Academy of Paediatric Dentistry·2017
Same author

Chemonucleolysis. Development, experience, perspectives.

Der Orthopade·2017

Chemonucleolysis, an intradiscal Chymopapain injection, offers a low-risk, minimally invasive treatment for lumbar disc prolapse with extensive clinical experience and good long-term results. It effectively bridges the gap between conservative care and open surgery.

Area of Science:

  • Neurosurgery
  • Minimally Invasive Procedures
  • Spinal Surgery

Background:

  • Lumbar disc prolapse necessitates effective treatment options.
  • Minimally invasive procedures are increasingly preferred for spinal conditions.
  • Chemonucleolysis has a long history of clinical application.

Purpose of the Study:

  • To evaluate chemonucleolysis as a minimally invasive treatment for lumbar disc prolapse.
  • To highlight the long-term efficacy and safety of intradiscal Chymopapain.
  • To position chemonucleolysis within the spectrum of spinal treatment modalities.

Main Methods:

  • Intradiscal application of Chymopapain.
  • Review of long-term clinical studies and patient outcomes.
  • Analysis of indications and contraindications, including allergic diathesis.

Related Experiment Videos

Main Results:

  • Chemonucleolysis demonstrates good long-term clinical results.
  • The procedure is characterized by a long period of clinical use and experience.
  • It is a low-risk and efficient therapeutic option.

Conclusions:

  • Chemonucleolysis is a well-established, minimally invasive therapy for lumbar disc prolapse.
  • It offers a valuable treatment option between conservative management and open surgery.
  • Careful patient selection, considering contraindications like allergic diathesis, is essential.